FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
-
By
-
Kathryn Wighton
-
June 15, 2026
-
3 min
By
Kathryn Wighton
June 15, 2026
Two cases highlight emergency reduction, vascular assessment, single-stage reconstruction, and rehabilitation following rare agricultural injuries
May 22, 2026